• No results found

Christina Sjöberg

N/A
N/A
Protected

Academic year: 2021

Share "Christina Sjöberg "

Copied!
2
0
0

Loading.... (view fulltext now)

Full text

(1)

Akademisk avhandling

som för avläggande av medicine doktorsexamen vid Sahlgrenska Akademin vid Göteborgs Universitet

offentligen kommer att försvaras i

Mölndalsaulan, Sahlgrenska Universitetssjukhuset/Mölndal fredagen den 1 februari 2013 kl 09:00

av

leg läkare Fakultetsopponent:

Docent Ellen Vinge, Lunds universitet Avhandlingen baseras på följande arbeten:

I. Sjöberg C, Bladh L, Klintberg L, Mellström D, Ohlsson C, Wallerstedt SM.

Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study.

Drugs Aging 2010;27(8):653-61

II. Sjöberg C, Wallerstedt SM. Improving treatment with fracture-preventing and fall-risk-increasing drugs in older hip fracture patients: effects of medication reviews performed by a physician – a randomised controlled study.

Submitted

III. Sjöberg C, Ohlsson H, Wallerstedt SM. Association between multi-dose drug dispensing and drug treatment changes.

Eur J Clin Pharmacol 2012;68(7):1095-101

IV. Sjöberg C, Edward C, Fastbom J, Johnell K, Landahl S, Narbro K, et al.

Association between multi-dose drug dispensing and quality of drug treatment - a register-based study.

PLoS One 2011;6(10):e26574

(2)

Christina Sjöberg

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine Sahlgrenska Academy at University of Gothenburg, Sweden

The aim of this thesis was to describe the quality of drug treatment regarding fall-risk- increasing and fracture-preventing drugs in older hip fracture patients, to evaluate a method for improving such treatment, and to study the effects of multi-dose drug dispensing on drug treatment changes and on quality of drug treatment.

A descriptive study of fall-risk-increasing and fracture-preventing drugs in a cohort of older hip fracture patients preceded a randomised controlled trial, in which the effects of an intervention regarding fall-risk-increasing and fracture-preventing drugs were investigated. A case-control study compared drug treatment changes of drugs prescribed via multi-dose drug dispensing or via ordinary prescriptions. In a register-based cross-sectional study quality of drug treatment was compared in patients with or without multi-dose drug dispensing regarding five indicators of prescribing quality.

In older hip fracture patients fall-risk-increasing drugs were common, whereas fracture- preventing drugs were scarce. Medication reviews performed by a physician improved the treatment with fracture-preventing drugs after one year, but did not affect the treatment with fall-risk-increasing drugs. The odds for a drug to remain unchanged after six months was greater for drugs prescribed via multi-dose drug dispensing. Potentially inappropriate drug treatment according to indicators for prescribing quality was more common for patients with multi-dose drug dispensing, also after adjustments for important covariates.

Quality of drug treatment in older hip fracture patients may be improved regarding fracture- preventing drugs, whereas extensive use of fall-risk-increasing drugs is more difficult to affect. Multi-dose drug dispensing is associated with poor quality of drug treatment, i.e. fewer drug treatment changes and higher prevalence of potentially inappropriate drugs. These findings need to be further evaluated and taken into account when designing multi-dose drug dispensing systems.

Keywords: older people, hip fracture, osteoporosis, medication review, prescribing, multi- dose drug dispensing, drug treatment, quality indicators

ISBN: 978-91-628-8576-2 http://hdl.handle.net/2077/31703 Gothenburg 2013

References

Related documents

- 7HATISTHEPATIENT REPORTEDOUTCOMEINOURDISTAL RADIUS FRACTURE COHORT WITH THE CURRENT TREATMENT PROTOCOL$OESASTANDARDIZEDTREATMENTPROTOCOL

The aim of this study was to describe and explore potential consequences for health-related quality of life, well-being and activity level, of having a certified service or

Alendronate prescribed to older patients (≥80 years) with prior fracture was associated with reduced risk of hip fracture by 38% with sustained safety. Alendronate prescribed

Male farmers had a decreased risk for hip fracture, and both female and male farmers had an increased risk for total hip replacement. Conclusion: A previous hip fracture in

Results During the period from initial fracture to initiation of bisphosphonate treatment, the incidence rate of any new clinical fracture was higher in those who later

Vancouver type B1 and interprosthetic femoral fractures (IPFF) ran a higher risk of a poor outcome in cases with cemented stem fixation and primary osteoarthritis at the

Each caseecontrol pair was excluded from further analyses if the case stopped using antipsychotics (de fined at 90 days after the last prescription was filled), if the control

The aim of this thesis was to describe the quality of drug treatment (QDT) regarding fall-risk increasing (FRIDs) and fracture-preventing (FPDs) drugs in older hip